INTEGRA LIFESCIENCES HOLDINGS CORP - 8-K Filing

Integra LifeSciences reports Q2 revenue growth above guidance (Items: 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITIONOn July 29, 2026, Integra LifeSciences Holdings Corporation (the “Company”) issued a press relea, 9.01 FINANCIAL STATEMENTS AND EXHIBITS(d) Exhibits99)

SEC EDGAR ·

Tickers: $IART

Read the full article at SEC EDGAR

More Regulatory news